US President Donald Trump has said that his government is planning a big tariff on imported medicines. This move is to push pharma companies to make their products inside America instead of depending on countries like China and India.
Speaking at a political event, Trump said that a “major” tariff is coming soon. He did not give the exact date or how much the tax would be. But he clearly said the goal is to bring back medicine manufacturing to the US.
India is one of the biggest suppliers of generic medicines and raw materials used in making drugs in the US. If this new US tariff is applied, it could directly affect Indian pharmaceutical exports. This can create a negative impact on listed Indian pharma companies like Sun Pharma, Cipla, Dr Reddy’s, and others, which have large US businesses.
Experts feel that this could also increase global medicine prices and hurt profit margins of Indian drugmakers who supply to the US market.
The Indian stock market may see some pressure on pharma stocks in the coming days due to this news. Investors will be closely watching for more details and the official timeline from the US government.
Do you have a news tip for Lakshmishree reporters? Please email us at media@lakshmishree.com.
Source: Moneycontrol.
News Desk
